Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (211-220 of 437) with videos related to

Pageof 44
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 15, 2024
Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysisDongfang Wang, Johannes Schneider-Thoma, Spyridon Siafis, et al.
Arthritis Research & Therapy|June 9, 2021
Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activityBenjamin Hur, Vinod K Gupta, Harvey Huang, et al.
Molecular Psychiatry|August 3, 2023
Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysisSpyridon Siafis, Hui Wu, Dongfang Wang, et al.
Rheumatology (Oxford, England)|August 31, 2023
Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespanMaria A Stevens, Hayley J Dykhoff, Vanessa L Kronzer, et al.
Cancer Biomarkers : Section a of Disease Markers|February 3, 2012
Confirmation of a potential biomarker for early-stage pancreatic cancerArthur A Topilow, John M Davis, Jerome J Vernick, et al.
Seminars in Arthritis and Rheumatism|October 16, 2024
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysisEdward Lovering, Chanakya Kodishala, Roslin Jose George, et al.
Comprehensive Psychoneuroendocrinology|May 20, 2024
Severe PTSD is marked by reduced oxytocin and elevated vasopressinAlexander J Horn, Steve Cole, Hans P Nazarloo, et al.
Arthritis Care & Research|June 20, 2022
Using Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-Based Cohort of Patients With Rheumatoid ArthritisCynthia S Crowson, Tina M Gunderson, John M Davis, et al.
Schizophrenia Research|February 19, 2021
Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysisGiulia Paris, Irene Bighelli, Giacomo Deste, et al.
Frontiers in Psychiatry|April 14, 2023
Deficits in odor discrimination versus odor identification in patients with schizophrenia and negative correlations with GABAergic and DNA methyltransferase mRNAs in lymphocytesRobert C Smith, Henry Sershen, Mary Youssef, et al.
Pageof 44

Showing results (211-220 of 437) with videos related to

Sort By:
Pageof 44
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 15, 2024
Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysisDongfang Wang, Johannes Schneider-Thoma, Spyridon Siafis, et al.
Arthritis Research & Therapy|June 9, 2021
Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activityBenjamin Hur, Vinod K Gupta, Harvey Huang, et al.
Molecular Psychiatry|August 3, 2023
Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysisSpyridon Siafis, Hui Wu, Dongfang Wang, et al.
Rheumatology (Oxford, England)|August 31, 2023
Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespanMaria A Stevens, Hayley J Dykhoff, Vanessa L Kronzer, et al.
Cancer Biomarkers : Section a of Disease Markers|February 3, 2012
Confirmation of a potential biomarker for early-stage pancreatic cancerArthur A Topilow, John M Davis, Jerome J Vernick, et al.
Seminars in Arthritis and Rheumatism|October 16, 2024
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysisEdward Lovering, Chanakya Kodishala, Roslin Jose George, et al.
Comprehensive Psychoneuroendocrinology|May 20, 2024
Severe PTSD is marked by reduced oxytocin and elevated vasopressinAlexander J Horn, Steve Cole, Hans P Nazarloo, et al.
Arthritis Care & Research|June 20, 2022
Using Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-Based Cohort of Patients With Rheumatoid ArthritisCynthia S Crowson, Tina M Gunderson, John M Davis, et al.
Schizophrenia Research|February 19, 2021
Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysisGiulia Paris, Irene Bighelli, Giacomo Deste, et al.
Frontiers in Psychiatry|April 14, 2023
Deficits in odor discrimination versus odor identification in patients with schizophrenia and negative correlations with GABAergic and DNA methyltransferase mRNAs in lymphocytesRobert C Smith, Henry Sershen, Mary Youssef, et al.
Pageof 44